In the News: November 17-23
Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links to related Sg2 resources.
CDC: Drug Poisoning and Falls Drive Increase in Accidental Death Rates
According to a recent CDC observational study, age-adjusted unintentional injury death rates increased by 6.6% from 2010 to 2014 in the US. This growth was driven largely by a 25% increase in poisonings and an 11% increase in falls. Meanwhile, across the 5 other leading causes of death, death rates declined for heart disease, cancer and stroke, and stabilized for chronic lower respiratory disease.
As the opioid epidemic in the US continues to strain existing services, progressive providers are implementing a multifaceted approach to address addiction and overdose. For leading examples of addiction and chemical dependency care redesign, watch Sg2’s recent behavioral health webinar.
Health Affairs: US Lags Other High-Income Countries in Providing Accessible, Affordable Care
According to a recent Health Affairs study, US adults reported greater financial barriers to care than adults from Australia, Canada, France, Germany, the Netherlands, Norway, Sweden, Switzerland and the United Kingdom. Of low-income adults in the US, 43% reported experiencing cost-related access problems, the highest rate among the countries surveyed. Adults across many of the industrialized countries surveyed also reported gaps in care coordination and chronic disease management.
To learn more about the components for successful population health management, explore Sg2’s resource kit.
AMA Adopts Principles to Promote Safe, Effective mHealth Applications
As more and more health systems adopt mobile health solutions, there is increasing variability in the functionality, accuracy, safety and effectiveness of the applications. The AMA recently adopted a list of principles to foster safe and effective use of mHealth apps, devices, trackers and sensors that are utilized by both patients and providers.
For Sg2’s perspective on key issues when evaluating investment in mobile health applications, read our recently updated Technology Guide.